790 related articles for article (PubMed ID: 15176082)
21. Antagonism of vasoactive intestinal peptide mRNA in the suprachiasmatic nucleus disrupts the rhythm of FRAs expression in neuroendocrine dopaminergic neurons.
Gerhold LM; Sellix MT; Freeman ME
J Comp Neurol; 2002 Aug; 450(2):135-43. PubMed ID: 12124758
[TBL] [Abstract][Full Text] [Related]
22. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
Joo KM; Chung YH; Kim MK; Nam RH; Lee BL; Lee KH; Cha CI
J Comp Neurol; 2004 Aug; 476(4):388-413. PubMed ID: 15282712
[TBL] [Abstract][Full Text] [Related]
23. Efferent projections of the suprachiasmatic nucleus in the golden hamster (Mesocricetus auratus).
Kalsbeek A; Teclemariam-Mesbah R; Pévet P
J Comp Neurol; 1993 Jun; 332(3):293-314. PubMed ID: 8331217
[TBL] [Abstract][Full Text] [Related]
24. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical evidence for different patterns in daily rhythms of VIP and AVP peptides in the suprachiasmatic nucleus of diurnal Funambulus palmarum.
Mammen AP; Jagota A
Brain Res; 2011 Feb; 1373():39-47. PubMed ID: 21156164
[TBL] [Abstract][Full Text] [Related]
26. Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat.
Watts AG; Swanson LW
J Comp Neurol; 1987 Apr; 258(2):230-52. PubMed ID: 2438309
[TBL] [Abstract][Full Text] [Related]
27. Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of nocturnal and diurnal rodents.
Dardente H; Menet JS; Challet E; Tournier BB; Pévet P; Masson-Pévet M
Brain Res Mol Brain Res; 2004 May; 124(2):143-51. PubMed ID: 15135222
[TBL] [Abstract][Full Text] [Related]
28. The role of the neuropeptides PACAP and VIP in the photic regulation of gene expression in the suprachiasmatic nucleus.
Dragich JM; Loh DH; Wang LM; Vosko AM; Kudo T; Nakamura TJ; Odom IH; Tateyama S; Hagopian A; Waschek JA; Colwell CS
Eur J Neurosci; 2010 Mar; 31(5):864-75. PubMed ID: 20180841
[TBL] [Abstract][Full Text] [Related]
29. Serotonin modulates expression of VIP and GRP mRNA via the 5-HT(1B) receptor in the suprachiasmatic nucleus of the rat.
Hayashi S; Ueda M; Amaya F; Matusda T; Tamada Y; Ibata Y; Tanaka M
Exp Neurol; 2001 Oct; 171(2):285-92. PubMed ID: 11573980
[TBL] [Abstract][Full Text] [Related]
30. Suprachiasmatic nucleus of the human brain: an immunocytochemical and morphometric analysis.
Hofman MA; Zhou JN; Swaab DF
Anat Rec; 1996 Apr; 244(4):552-62. PubMed ID: 8694290
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneous expression of gamma-aminobutyric acid and gamma-aminobutyric acid-associated receptors and transporters in the rat suprachiasmatic nucleus.
Belenky MA; Yarom Y; Pickard GE
J Comp Neurol; 2008 Feb; 506(4):708-32. PubMed ID: 18067149
[TBL] [Abstract][Full Text] [Related]
32. Two types of VIP neuronal components in rat suprachiasmatic nucleus.
Kawamoto K; Nagano M; Kanda F; Chihara K; Shigeyoshi Y; Okamura H
J Neurosci Res; 2003 Dec; 74(6):852-7. PubMed ID: 14648589
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat.
Baun M; Hay-Schmidt A; Edvinsson L; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2011 Nov; 670(1):186-94. PubMed ID: 21914446
[TBL] [Abstract][Full Text] [Related]
34. Basal forebrain neurons modulate the synthesis and expression of neuropeptides in the rat suprachiasmatic nucleus.
Madeira MD; Pereira PA; Silva SM; Cadete-Leite A; Paula-Barbosa MM
Neuroscience; 2004; 125(4):889-901. PubMed ID: 15120850
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
36. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal peptide efferent projections of the suprachiasmatic nucleus in anterior hypothalamic transplants: correlation with functional restoration of circadian behavior.
Sollars PJ; Pickard GE
Exp Neurol; 1995 Nov; 136(1):1-11. PubMed ID: 7589329
[TBL] [Abstract][Full Text] [Related]
38. Lack of the PAC1 receptor alters the circadian expression of VIP mRNA in the suprachiasmatic nucleus of mice.
Georg B; Hannibal J; Fahrenkrug J
Brain Res; 2007 Mar; 1135(1):52-7. PubMed ID: 17196185
[TBL] [Abstract][Full Text] [Related]
39. Colocalization of gamma-aminobutyric acid with vasopressin, vasoactive intestinal peptide, and somatostatin in the rat suprachiasmatic nucleus.
Buijs RM; Wortel J; Hou YX
J Comp Neurol; 1995 Jul; 358(3):343-52. PubMed ID: 7560291
[TBL] [Abstract][Full Text] [Related]
40. Distribution of pituitary adenylate cyclase-activating polypeptide and pituitary adenylate cyclase-activating polypeptide type I receptor mRNA in the chicken brain.
Peeters K; Gerets HH; Arckens L; Vandesande F
J Comp Neurol; 2000 Jul; 423(1):66-82. PubMed ID: 10861537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
